首页> 外国专利> METHODS FOR TREATING TYPE 2 DIABETES IN PATIENTS RESISTANT TO PREVIOUS TREATMENT WITH OTHER ANTI-DIABETIC DRUGS EMPLOYING SGLT2 INHIBITOR AND COMPOSITIONS THEREOF

METHODS FOR TREATING TYPE 2 DIABETES IN PATIENTS RESISTANT TO PREVIOUS TREATMENT WITH OTHER ANTI-DIABETIC DRUGS EMPLOYING SGLT2 INHIBITOR AND COMPOSITIONS THEREOF

机译:使用SGLT2抑制剂和其他抗糖尿病药物治疗过往抗药性患者的2型糖尿病的方法及其组成

摘要

PROBLEM TO BE SOLVED: To provide methods for treating a patient having type 2 diabetes who has failed on previous regimens of one or more oral and/or injectable anti-diabetic agents.SOLUTION: The invention provides methods of administering a therapeutically effective amount of an SGLT2 inhibitor represented by the following formula alone or in combination with another anti-diabetic agent and/or other therapeutic agent to such a patient; and a pharmaceutical composition containing dapagliflozin or dapagliflozin-S-propylene glycol solvate and one or more diabetic agents and/or other therapeutic agents.SELECTED DRAWING: None
机译:要解决的问题:提供用于治疗在先前的一种或多种口服和/或注射用抗糖尿病药治疗方案中均无效的2型糖尿病患者的方法。解决方案:本发明提供了治疗有效量的2型糖尿病患者的治疗方法。由下式代表的SGLT2抑制剂单独或与另一种抗糖尿病药和/或其他治疗剂组合用于此类患者;以及含有达格列净或达格列净-S-丙二醇溶剂化物和一种或多种糖尿病药物和/或其他治疗药物的药物组合物。

著录项

  • 公开/公告号JP2016104753A

    专利类型

  • 公开/公告日2016-06-09

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;ASTRAZENECA UK LTD;

    申请/专利号JP20150241499

  • 发明设计人 PAUL STRUMPH;STEPHANIE MORAN;JAMES LIST;

    申请日2015-12-10

  • 分类号A61K45;A61K45/06;A61K38/28;A61K31/155;A61K31/517;A61K31/4439;A61K31/64;A61K31/195;A61K38/22;A61K31/616;A61K31/4409;A61K31/4365;A61K31/403;A61K31/40;A61P3/10;A61P43;A61P5/50;A61K31/351;

  • 国家 JP

  • 入库时间 2022-08-21 14:44:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号